Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Analog Devices enters the final stretch before its November 25 earnings with a striking split: the stock is up 13% over the past month and analysts are broadly bullish, while every insider who has traded recently has been a seller.
The insider flow is the most notable feature of the current setup. Net open-market activity over the past 90 days totals roughly $18.3 million in sales across 48,587 shares. CEO Vincent Roche sold 10,000 shares at $396.94 on October 1, netting just under $4 million, though that transaction ran through a pre-arranged 10b5-1 plan. CFO Richard Puccio sold 1,500 shares on October 6 at $421.08 under a 10b5-1 plan as well. Less straightforward are two October 2 sales from the Chief Customer Officer and Chief Operations Officer, neither of which carried a 10b5-1 disclosure, totalling around $1.3 million combined. Planned sales are a weaker signal than discretionary ones, but the cluster of activity across multiple senior roles in a single week is worth noting.
The lending market tells a different story from the insider register: short sellers are not pressing the trade. Short interest is a modest 1.7% of free float, up just 0.2% over the week. Availability is entirely unconstrained, with the borrow pool effectively limitless relative to demand. Cost to borrow is 0.40%, near the bottom of its 30-day range. Options positioning is calm: the put/call ratio of 0.50 sits less than one standard deviation above its 20-day mean of 0.47, well below the 52-week high of 1.0. None of these readings suggest a market leaning hard against the stock. Short positioning looks closer to indifferent than bearish.
The Street is more constructive. The consensus rating is a buy, with a mean price target near $471, roughly 15% above Wednesday's close of $410. Most of the post-earnings analyst moves in August pushed targets higher. Bernstein upgraded to Outperform and lifted its target to $465. JPMorgan raised to $500 and Morgan Stanley moved to $458, both maintaining Overweight. Baird went furthest, lifting its target to $675, a significant outlier relative to the cluster. Only Wells Fargo trimmed its target, cutting to $500 from $515 while keeping its Overweight. The bull case centres on AI datacenter exposure, with ADI claiming datacenter revenue above $3 billion and optical and power growing more than 100% year over year, alongside rising gross margin guidance. The bear case flags inventory risk, with days inventory outstanding elevated at 156 days, and the cyclical sensitivity of a business tied to global industrial and automotive demand. It is worth noting that the analyst consensus data is from mid-September, so some of the individual targets predate recent price moves.
Valuation has expanded with the rally. The price-to-earnings multiple has risen by 2.5 points over the past 30 days to around 26.4x. EV/EBITDA has come in slightly over the same period, now at 20x. The dividend score ranks in the 97th percentile of the universe, though the dividend history in the data is stale and the current yield should be independently verified. The days-to-cover rank of 80 reflects how lightly shorted the stock is. Wikipedia page views, one proxy for retail attention, have fallen to 1.5 standard deviations below their own 90-day average, suggesting the recent price run is not drawing fresh retail interest.
Closest peers pulled back more sharply on the day: ON Semiconductor fell 4.4% and Microchip Technology dropped 4.0%, while Texas Instruments slipped 2.8%, all on the same session that ADI gave back 2.5%. On the week, ADI's 3.4% gain keeps pace with TXN's 3.2% but trails ON's 7.3% and Monolithic Power Systems at 5.8%.
With earnings 48 days out, the question for the November 25 print is less whether the AI datacenter narrative holds and more whether inventory levels at customers have normalised enough to support guidance for the cycle ahead.
See the live data behind this article on ORTEX.
Open ADI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
